517 results on '"Hay, David C."'
Search Results
52. Comments of the AFAANZ auditing and assurance standards committee on proposed international standard on auditing ISA for LCE
53. Public sector audit in uncertain times
54. Stem cell–derived models to improve mechanistic understanding and prediction of human drug‐induced liver injury
55. Nuclear factor programming improves stem-cell-derived hepatocyte phenotype
56. Maternal over-the-counter analgesics use during pregnancy and adverse perinatal outcomes: cohort study of 151 141 singleton pregnancies
57. Human biliary epithelial cells from discarded donor livers rescue bile duct structure and function in a mouse model of biliary disease
58. Heliyon Developmental and Stem Cell Biology: Furthering our understanding of the beginning, the middle, and the end
59. Highly Efficient Differentiation of hESCs to Functional Hepatic Endoderm Requires ActivinA and Wnt3a Signaling
60. Unbiased screening of polymer libraries to define novel substrates for functional hepatocytes with inducible drug metabolism
61. The ungreening of integrated reporting: a reflection on regulatory capture
62. Pluripotent Stem Cell-Derived Hepatocytes Inhibit T Cell Proliferation In Vitro through Tryptophan Starvation
63. The going-concern opinion and the adverse credit rating: an analysis of their relationship
64. Post-translational modification by SUMO
65. Pluripotent stem cell derived hepatocyte like cells and their potential in toxicity screening
66. External Factors and the Pricing of Audit Services: A Systematic Review of the Archival Literature Using a PESTLE Analysis
67. Polymer Supported Directed Differentiation Reveals a Unique Gene Signature Predicting Stable Hepatocyte Performance
68. Maternal Smoking Dysregulates Protein Expression in Second Trimester Human Fetal Livers in a Sex-Specific Manner
69. Galectin-3 regulates hepatic progenitor cell expansion during liver injury
70. Serum-Free Directed Differentiation of Human Embryonic Stem Cells to Hepatocytes
71. Public sector audit in uncertain times
72. Protocol for automated production of human stem cell derived liver spheres
73. Modeling human hepatic steatosis in pluripotent stem cell-derived hepatocytes
74. Stem Cell-Based Toxicity Screening: Recent Advances in Hepatocyte Generation
75. Chapter 39 - Liver stem cells
76. Progress and future challenges in stem cell-derived liver technologies
77. External Factors and the Pricing of Audit Services: A Systematic Review of the Archival Literature Using a PESTLE Analysis.
78. Comments of the AFAANZ Auditing and Assurance Standards Committee on Proposed International Standard on Auditing 600 (ED 600)
79. Discussion of “The Quality of Mandatory Nonfinancial Risk Disclosures and the Moderating Effect of Audit Firm and Partner Characteristics”
80. Genome-wide expression changes induced by bisphenol A, F and S in human stem cell derived hepatocyte-like cells
81. Erratum to: Modelling foetal exposure to maternal smoking using hepatoblasts from pluripotent stem cells
82. Importance of country factors for global differences in audit pricing: New empirical evidence
83. Mathematical modelling of oxygen gradients in stem cell-derived liver tissue
84. Pluripotent Stem Cell Models in Human Drug Development
85. Liver tissue engineering and cell sources: issues and challenges
86. Deriving Metabolically Active Hepatic Endoderm from Pluripotent Stem Cells
87. Novel Biopolymers to Enhance Endothelialisation of Intra-vascular Devices
88. Persistence of functional hepatocyte-like cells in immune-compromised mice
89. The future of auditing research in the public sector
90. Over-the-counter analgesics during pregnancy: a comprehensive review of global prevalence and offspring safety
91. Over-the-counter Analgesics in Pregnancy and Offspring Neonatal Outcomes: A Retrospective Cohort Study
92. Macrovesicular steatosis in nonalcoholic fatty liver disease is a consequence of purine nucleotide cycle driven fumarate accumulation
93. Human PSC-Derived Hepatocytes Express Low Levels of Viral Pathogen Recognition Receptors, but Are Capable of Mounting an Effective Innate Immune Response
94. Hepatic Progenitor Specification from Pluripotent Stem Cells using a Defined Differentiation System
95. Introducing Point Mutations into Human Pluripotent Stem Cells Using Seamless Genome Editing
96. Portal venous endothelium in developing human liver contains haematopoietic and epithelial progenitor cells
97. Generation of Functional Human Hepatic Endoderm From Human Induced Pluripotent Stem Cells
98. EVENTS AND TIMING
99. ACTIVITIES, FUNCTIONS, AND PROCESSES
100. ABOUT METADATA MODELS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.